Indigo Diabetes raised €38M in a Series B round in Jul 2020. The company is based in Zwijnaarde, Belgium. Investors in the round: Fund+. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €38M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
